Trials
Search / Trial NCT06429774

Comparative Effectiveness of Intervention in Multi-level Hospitals for Acute Traumatic Brain Injury(Metric-TBI)

Launched by BEIJING TIANTAN HOSPITAL · May 23, 2024

Trial Information

Current as of February 19, 2025

Recruiting

Keywords

Traumatic Brain Injury Beijing Tianjin Hebei Region Database Comparative Effectiveness Of Intervention Clinical Treatment Guideline

ClinConnect Summary

The Metric-TBI trial is studying the best ways to treat patients with acute traumatic brain injury (TBI) in different hospitals. This research aims to find out which treatment methods work best to help patients recover and improve their health outcomes. The trial is currently looking for participants, including people aged 1 to 89 who have symptoms of TBI and have been diagnosed through imaging tests like CT scans or MRIs.

To join the study, patients or their family members must give written consent, and participants will need to attend follow-up visits to track their progress. However, individuals over 90 years old, those with other serious illnesses, or who cannot provide complete information will not be included. If eligible, participants can expect to contribute to important research that could improve treatment options for TBI in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient (1 years to 89 years) presenting with clinical symptoms of traumatic brain injury
  • Traumatic brain injury verified on cranial computed tomography or magnetic resonance imaging
  • Written informed consent from patients or their next of kin according to the patient's cognitive status
  • Exclusion Criteria:
  • patients ≥90 years of age
  • patients who did not accept follow-up visits or were unable to complete follow-up assessments
  • patients with incomplete information
  • patients who did not obtain written informed consent
  • patients with concomitant cancer or other serious illnesses

Trial Officials

Weiming Liu, M.D.

Principal Investigator

Beijing Tiantan Hospital

About Beijing Tiantan Hospital

Beijing Tiantan Hospital, affiliated with Capital Medical University, is a leading medical institution in China renowned for its expertise in neurology, neurosurgery, and various other specialties. As a prominent clinical trial sponsor, the hospital is committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on high-quality clinical trials, Beijing Tiantan Hospital adheres to rigorous ethical standards and regulatory requirements, fostering collaboration with academic institutions and industry partners to facilitate the development of cutting-edge therapies and interventions. Its state-of-the-art facilities and experienced research team enable the hospital to play a pivotal role in the global medical research landscape.

Locations

Beijing, Beijing, China

Beijing, , China

Beijing, Beijing, China

Chengde, Hebei, China

Shijiazhuang, Hebei, China

Beijing, Beijing, China

Shijiazhuang, Hebei, China

Xingtai, Hebei, China

Shijiazhuang, Hebei, China

Baoding, Hebei, China

Tianjin, Tianjin, China

Beijing, , China

Beijing, Beijing, China

Handan, Hebei, China

Tangshan, Hebei, China

Langfang, Hebei, China

Tianjin, Tianjin, China

Beijing, Beijing, China

Beijing, Beijing, China

Beijing, Beijing, China

Beijing, Beijing, China

Beijing, Beijing, China

Beijing, Beijing, China

Beijing, Beijing, China

Beijing, Beijing, China

Beijing, Beijing, China

Beijing, Beijing, China

Beijing, Beijing, China

Baoding, Hebei, China

Baoding, Hebei, China

Baoding, Hebei, China

Baoding, Hebei, China

Baoding, Hebei, China

Baoding, Hebei, China

Cangzhou, Hebei, China

Chengde, Hebei, China

Handan, Hebei, China

Handan, Hebei, China

Handan, Hebei, China

Hengyang, Hebei, China

Langfang, Hebei, China

Langfang, Hebei, China

Langfang, Hebei, China

Langfang, Hebei, China

Shijiazhuang, Hebei, China

Shijiazhuang, Hebei, China

Shijiazhuang, Hebei, China

Shijiazhuang, Hebei, China

Shijiazhuang, Hebei, China

Shijiazhuang, Hebei, China

Tangshan, Hebei, China

Tangshan, Hebei, China

Xingtai, Hebei, China

Xingtai, Hebei, China

Xingtai, Hebei, China

Beijing, Beijing, China

Beijing, Beijing, China

Baoding, Hebei, China

Baoding, Hebei, China

Baoding, Hebei, China

Chengde, Hebei, China

Langfang, Hebei, China

Langfang, Hebei, China

Langfang, Hebei, China

Langfang, Hebei, China

Qinhuangdao, Hebei, China

Qinhuangdao, Hebei, China

Qinhuangdao, Hebei, China

Qinhuangdao, Hebei, China

Qinhuangdao, Hebei, China

Shijia Zhuang, Hebei, China

Xingtai, Hebei, China

Xingtai, Hebei, China

Xingtai, Hebei, China

Xingtai, Hebei, China

Xingtai, Hebei, China

Xingtai, Hebei, China

Tianjin, Tianjin, China

Tianjin, Tianjin, China

Tianjin, Tianjin, China

Langfang, Hebei, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0